Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Grimm

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cancers|June 10, 2022
Intra- and Interobserver Variability of Shear Wave Elastography in Rectal CancerMartina Kastrup Loft, Malene Roland Vils Pedersen, Peter Grimm, et al.
Journal of Contemporary Brachytherapy|October 22, 2013
Permanent prostate brachytherapy extracapsular radiation dose distributions: analysis of a multi-institutional databaseGregory S Merrick, Wayne M Butler, Peter Grimm, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 7, 2012
The dynamics of Aβ distribution after γ-secretase inhibitor treatment, as determined by experimental and modelling approaches in a wild type ratLeon M Tai, Helmut Jacobsen, Laurence Ozmen, et al.
Brachytherapy|February 16, 2010
Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activityGregory S Merrick, John Sylvester, Peter Grimm, et al.
Brachytherapy|March 12, 2013
Impact of small prostate size on postimplant prostate dosimetry: analysis of a large community databaseAl V Taira, Gregory S Merrick, Peter Grimm, et al.
Journal of Pharmaceutical Sciences|July 29, 2019
PKPD Assessment of the Anti-CD20 Antibody Obinutuzumab in Cynomolgus Monkey is Feasible Despite Marked Anti-Drug Antibody Response in This SpeciesHans Peter Grimm, Eginhard Schick, Dominik Hainzl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 24, 2008
Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro modelAgnès Poirier, Thierry Lavé, Renée Portmann, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|August 5, 2008
Influence of Pro-Qura-generated plans on postimplant dosimetric quality: a review of a multi-institutional databaseZachariah Allen, Gregory S Merrick, Peter Grimm, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 23, 2022
Learn-confirm in model-informed drug development: Assessing an immunogenicity quantitative systems pharmacology platformLinnea C Franssen, Maciej J Swat, Andrzej M Kierzek, et al.
The AAPS Journal|April 5, 2020
Subcutaneous Site-of-Absorption Study with the Monoclonal Antibody Tocilizumab in Minipigs: Administration Behind Ear Translates Best to HumansWolfgang F Richter, Hans-Peter Grimm, Marie-Hélène Gouy, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancers|June 10, 2022
Intra- and Interobserver Variability of Shear Wave Elastography in Rectal CancerMartina Kastrup Loft, Malene Roland Vils Pedersen, Peter Grimm, et al.
Journal of Contemporary Brachytherapy|October 22, 2013
Permanent prostate brachytherapy extracapsular radiation dose distributions: analysis of a multi-institutional databaseGregory S Merrick, Wayne M Butler, Peter Grimm, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 7, 2012
The dynamics of Aβ distribution after γ-secretase inhibitor treatment, as determined by experimental and modelling approaches in a wild type ratLeon M Tai, Helmut Jacobsen, Laurence Ozmen, et al.
Brachytherapy|February 16, 2010
Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activityGregory S Merrick, John Sylvester, Peter Grimm, et al.
Brachytherapy|March 12, 2013
Impact of small prostate size on postimplant prostate dosimetry: analysis of a large community databaseAl V Taira, Gregory S Merrick, Peter Grimm, et al.
Journal of Pharmaceutical Sciences|July 29, 2019
PKPD Assessment of the Anti-CD20 Antibody Obinutuzumab in Cynomolgus Monkey is Feasible Despite Marked Anti-Drug Antibody Response in This SpeciesHans Peter Grimm, Eginhard Schick, Dominik Hainzl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 24, 2008
Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro modelAgnès Poirier, Thierry Lavé, Renée Portmann, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|August 5, 2008
Influence of Pro-Qura-generated plans on postimplant dosimetric quality: a review of a multi-institutional databaseZachariah Allen, Gregory S Merrick, Peter Grimm, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 23, 2022
Learn-confirm in model-informed drug development: Assessing an immunogenicity quantitative systems pharmacology platformLinnea C Franssen, Maciej J Swat, Andrzej M Kierzek, et al.
The AAPS Journal|April 5, 2020
Subcutaneous Site-of-Absorption Study with the Monoclonal Antibody Tocilizumab in Minipigs: Administration Behind Ear Translates Best to HumansWolfgang F Richter, Hans-Peter Grimm, Marie-Hélène Gouy, et al.
Pageof 5